Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 193

Stoke Therapeutics swells IPO to $163m

The gene therapy developer has boosted its initial public offering, which gave an exit to Alexandria Real Estate Equities, to more than $163m in size.

Jun 24, 2019

DataRobot parks itself at ParallelM

Intel has exited machine learning technology developer ParallelM, which has been bought by DataRobot in a deal reportedly sized at tens of millions of dollars.

Jun 21, 2019

Tokopedia ties a knot in Bridestory acquisition

Tokopedia has bought the online wedding marketplace and its parental services subsidiary, Parentstory, handing exits to Lippo Group and Rocket Internet.

Jun 21, 2019

Slack slides into public markets

The SoftBank, Comcast and Alphabet-backed communication platform developer saw its shares pop and its market cap climb nearly 50% to $19.5bn following its direct listing.

Jun 21, 2019

Investors drive Druva forward with $130m

NTT-backed data management software producer Druva has closed a $130m round led by Viking Global Investors and acquired M12-backed data transfer platform CloudLanes.

Jun 21, 2019

Niantic picks up Sensible Object

The mobile game studio has acquired interactive tabletop game maker Sensible Object, handing exits to Amazon and NCSoft.

Jun 20, 2019

Saft takes acquisition route to Go Electric

Battery technology manufacturer Saft has purchased the back-up energy system provider in a transaction that enabled Evergy Ventures to exit.

Jun 20, 2019

Prevail sails to $125m IPO

The AbbVie Ventures-backed neurodegenerative disease treatment developer floated in the middle of its range having previously raised $129m in funding.

Jun 20, 2019

Stoke Therapeutics sticks landing on $142m IPO

The Alexandria Venture Investments-backed genetic disease therapy developer is floating above its range having increased the number of shares in the offering.

Jun 19, 2019

Allscripts wraps up ZappRx acquisition

GlaxoSmithKline and Alphabet have exited the online drug delivery platform, which has been acquired by Allscripts in a deal reported to be less than $40m in size.

Jun 18, 2019

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here